Table 3.
Hepatitis A vaccination: estimated (weighted) prevalence of hepatitis A vaccination in German children and adolescents (aged 3–17 years) by demographic characteristics and (weighted) results of univariable and multivariable analysis (n = 12,249).
| Characteristic (total no.) | (weighted) prevalence | (weighted) univariable analysis | (weighted) multivariable analysis | ||
|---|---|---|---|---|---|
| % (95% CI) | Odds ratio (95% CI) | p-value | Odds ratio (95% CI) | p-value | |
| Vaccination card accessible (12,249) | 10.51 (9.31–11.84) | — | — | — | — |
| Age (yearly) | — | 1.13 (1.11–1.15) | <0.001 | 1.12 (1.09–1.13) | <0.001 |
| Sex | |||||
| male (6,282) | 10.30 (8.95–11.84) | ref. | — | — | — |
| female (5,967) | 10.73 (9.51–12.08) | 1.05 (0.94–1.17) | 0.423 | — | — |
| Place of residence | |||||
| North-West (1,503) | 5.57 (4.34–7.12) | ref. | — | ref. | — |
| Central-West (2,877) | 7.12 (5.98–8.46) | 1.30 (0.94–1.80) | 0.110 | 1.29 (0.94–1.79) | 0.119 |
| South-West (3,655) | 12.08 (9.91–14.65) | 2.33 (1.65–3.29) | <0.001 | 2.33 (1.63–3.33) | <0.001 |
| North-East (1,335) | 12.11 (9.06–16.00) | 2.34 (1.54–3.55) | <0.001 | 2.11 (1.37–3.25) | 0.001 |
| Central-East (2,516) | 23.66 (19.13–28.87) | 5.26 (3.61–7.66) | <0.001 | 4.99 (3.38–7.39) | <0.001 |
| Berlin (363) | 8.95 (6.61–12.02) | 1.67 (1.10–2.54) | 0.017 | 1.66 (1.06–2.61) | 0.028 |
| Populationsize of municipality | |||||
| <5,000 (rural area) (2,763) | 12.44 (8.16–16.72) | ref. | — | — | — |
| 5,000–<20,0000 (small town) (3,298) | 11.29 (8.79–13.79) | 0.90 (0.56–1.43) | 0.642 | — | — |
| 20,000–<100,0000 (medium-sized town) (3,505) | 9.15 (7.44–10.86) | 0.71 (0.45–1.10) | 0.127 | — | — |
| >100,000 (large town) (2,683) | 9.78 (7.87–11.69) | 0.76 (0.49–1.19) | 0.235 | — | — |
| Socio-economic status | |||||
| low (3,103) | 8.56 (6.96–10.49) | ref. | — | ref. | — |
| medium (5,767) | 10.26 (8.94–11.75) | 1.22 (1.01–1.48) | 0.044 | 1.16 (0.95–1.41) | 0.149 |
| high (3,156) | 12.83 (11.11–14.77) | 1.57 (1.24–1.99) | <0.001 | 1.67 (1.33–2.09) | <0.001 |
| unknown (223) | — | — | — | — | — |
| Migration status | |||||
| Non-migrant (9,738) | 10.64 (9.31–12.13) | ref. | — | — | — |
| One-sided (819) | 11.07 (8.69–14.00) | 1.05 (0.79–1.39) | 0.754 | — | — |
| Two-sided (1,649) | 9.69 (7.92–11.81) | 0.90 (0.72–1.13) | 0.357 | — | — |
| unknown (43) | — | — | — | — | — |
The results refer to a subsample of study participants with HAV serology and accessible vaccination cards (see Fig. 1).